abstract |
The present invention relates to novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies and therapeutic compositions comprising an isolated nucleic acid encoding at least one anti-IL-6 antibody, vector, host cell, transgenic animal or plant And methods of making and using them, including methods and apparatus. |